Material Safety Data Sheet 1. PRODUCT AND COMPANY IDENTIFICATION
3050 Spruce Street SAINT LOUIS MO 63103 USA
2. COMPOSITION/INFORMATION ON INGREDIENTS Ethionamide 536-33-4 3. HAZARDS IDENTIFICATION Emergency Overview OSHA Hazards Target Organ Effect, Harmful by ingestion., Teratogen Target Organs HMIS Classification Health Hazard: Chronic Health Hazard: Flammability: Physical hazards: NFPA Rating Health Hazard: Reactivity Hazard: Potential Health Effects Inhalation
May be harmful if inhaled. May cause respiratory tract irritation.
May be harmful if absorbed through skin. May cause skin irritation.
Ingestion 4. FIRST AID MEASURES General advice Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area. If inhaled If breathed in, move person into fresh air. If not breathing give artificial respiration Consult a physician. In case of skin contact Wash off with soap and plenty of water. Consult a physician. In case of eye contact Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 5. FIRE-FIGHTING MEASURES Flammable properties Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special protective equipment for fire-fighters Wear self contained breathing apparatus for fire fighting if necessary. 6. ACCIDENTAL RELEASE MEASURES Personal precautions Use personal protective equipment. Avoid dust formation. Avoid breathing dust. Ensure adequate ventilation. Environmental precautions Do not let product enter drains. Methods for cleaning up Pick up and arrange disposal without creating dust. Keep in suitable, closed containers for disposal. 7. HANDLING AND STORAGE Handling Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire protection. Storage Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: 2 - 8 °C
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Contains no substances with occupational exposure limit values.
Personal protective equipment Respiratory protection Where risk assessment shows air-purifying respirators are appropriate use a dust mask type N95 (US) or type P1 (EN 143) respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Hand protection Handle with gloves. Eye protection Safety glasses with side-shields conforming to EN166 Skin and body protection Choose body protection according to the amount and concentration of the dangerous substance at the work place. Hygiene measures Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. 9. PHYSICAL AND CHEMICAL PROPERTIES Appearance Safety data 10. STABILITY AND REACTIVITY Storage stability Stable under recommended storage conditions. Materials to avoid Strong oxidizing agents Hazardous decomposition products Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx), Sulphur oxides 11. TOXICOLOGICAL INFORMATION Acute toxicity Irritation and corrosion Sensitisation Chronic exposure
This product is or contains a component that is not classifiable as to its carcinogenicity based on its IARC, ACGIH, NTP, or EPA classification.
3 - Group 3: Not classifiable as to its carcinogenicity to humans (Ethionamide)
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by ACGIH.
No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP.
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA.
Laboratory experiments have shown teratogenic effects.
Signs and Symptoms of Exposure
Gastrointestinal disturbance, Dermatitis, Liver injury may occur., Convulsions
Potential Health Effects Inhalation
May be harmful if inhaled. May cause respiratory tract irritation.
May be harmful if absorbed through skin. May cause skin irritation.
Ingestion Target Organs Additional Information RTECS: NS0350000 12. ECOLOGICAL INFORMATION Elimination information (persistence and degradability) Ecotoxicity effects Further information on ecology 13. DISPOSAL CONSIDERATIONS Product Observe all federal, state, and local environmental regulations. Contact a licensed professional waste disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Contaminated packaging Dispose of as unused product. 14. TRANSPORT INFORMATION DOT (US) Not dangerous goods IMDG Not dangerous goods IATA Not dangerous goods 15. REGULATORY INFORMATION OSHA Hazards Target Organ Effect, Harmful by ingestion., Teratogen DSL Status This product contains the following components that are not on the Canadian DSL nor NDSL lists. SARA 302 Components SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302. SARA 313 Components SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313. SARA 311/312 Hazards Acute Health Hazard, Chronic Health Hazard Massachusetts Right To Know Components No components are subject to the Massachusetts Right to Know Act. Pennsylvania Right To Know Components New Jersey Right To Know Components California Prop. 65 Components
WARNING! This product contains a chemical known in the State of
California to cause birth defects or other reproductive harm.
16. OTHER INFORMATION Further information Copyright 2009 Sigma-Aldrich Co. License granted to make unlimited paper copies for internal use only. The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Sigma-Aldrich Co., shall not be held liable for any damage resulting from handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.
Portaria nº 843 de 06 de Novembro de 2002. O Secretário de Assistência à Saúde, no uso de suas atribuições legais, Considerando a necessidade de estabelecer Protocolo Clínico e Diretrizes Terapêuticas para o tratamento da Demência por Doença de Alzheimer, que contenha critérios de diagnóstico e tratamento, observando ética e tecnicamente a prescrição médica, racionalize a d
Newer Anti-epileptic Drugs in the Veterinary Patient Stacy Dillard, DVM, Dip. ACVIM (Neurology) There are several anti-epiletic drugs (AED) that are being used with more frequency in our veterinary patients with recurrent seizures. Many of these drugs have been used in human epilepsy for many years and were developed for alternative mechanisms of action as well as a higher safety profi